{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:53:09Z","timestamp":1791514389267,"version":"4.3.4"},"update-to":[{"DOI":"10.1371\/journal.pntd.0007325","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:00:00Z","timestamp":1559692800000}}],"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T00:00:00Z","timestamp":1558310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPPGH532"],"award-info":[{"award-number":["OPPGH532"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0007325","type":"journal-article","created":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T17:34:06Z","timestamp":1558373646000},"page":"e0007325","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in C\u00f4te d\u2019Ivoire"],"prefix":"10.1371","volume":"13","author":[{"given":"Constant","family":"Edi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Bjerum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3856-8406","authenticated-orcid":true,"given":"Allassane F.","family":"Ouattara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashpal S.","family":"Chhonker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis K.","family":"Penali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aboulaye","family":"M\u00e9it\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin G.","family":"Koudou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary J.","family":"Weil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3873-7860","authenticated-orcid":true,"given":"Christopher L.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl J.","family":"Murry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,5,20]]},"reference":[{"issue":"40","key":"ref1","first-page":"594","article-title":"Global programme to eliminate lymphatic filariasis: progress report","volume":"92","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"issue":"9","key":"ref2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1365-3156.2000.00620.x","article-title":"The global programme to eliminate lymphatic filariasis","volume":"5","author":"EA Ottesen","year":"2000","journal-title":"Tropical medicine & international health: TM & IH"},{"key":"ref3","unstructured":"WHO. The Global Programme to Eliminate Lymphatic Filariasis: Progress Report 2000\u20132009 and Strategic Plan 2010\u20132020. Geneva: 2011."},{"issue":"10","key":"ref4","first-page":"e317","article-title":"The global programme to eliminate lymphatic filariasis: health impact after 8 years. PLoS neglected tropical diseases","volume":"2","author":"EA Ottesen","year":"2008"},{"issue":"19","key":"ref5","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1706854","article-title":"A Trial of a Triple-Drug Treatment for Lymphatic Filariasis","volume":"379","author":"CL King","year":"2018","journal-title":"The New England journal of medicine"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/cid\/civ882","article-title":"Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis","volume":"62","author":"EK Thomsen","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/clpt.2008.302","article-title":"Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics","volume":"85","author":"ET Morgan","year":"2009","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.4269\/ajtmh.15-0916","article-title":"Measurement of Circulating Filarial Antigen Levels in Human Blood with a Point-of-Care Test Strip and a Portable Spectrodensitometer","volume":"94","author":"CB Chesnais","year":"2016","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"e0005163","DOI":"10.1371\/journal.pntd.0005163","article-title":"Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa","volume":"11","author":"PU Fischer","year":"2017","journal-title":"PLoS neglected tropical diseases"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.pt.2015.06.007","article-title":"Diagnostic Tools for Onchocerciasis Elimination Programs","volume":"31","author":"J Vlaminck","year":"2015","journal-title":"Trends in parasitology"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-3156.1996.d01-79.x","article-title":"Ultrasonographic assessment of the adulticidal efficacy of repeat high-dose ivermectin in bancroftian filariasis","volume":"1","author":"G Dreyer","year":"1996","journal-title":"Tropical medicine & international health: TM & IH"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jpba.2017.12.037","article-title":"LC-MS\/MS method for simultaneous determination of diethylcarbamazine, albendazole and albendazole metabolites in human plasma: Application to a clinical pharmacokinetic study","volume":"151","author":"YS Chhonker","year":"2018","journal-title":"Journal of pharmaceutical and biomedical analysis"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jpba.2005.08.026","article-title":"Liquid chromatographic assay of ivermectin in human plasma for application to clinical pharmacokinetic studies","volume":"40","author":"D Kitzman","year":"2006","journal-title":"Journal of pharmaceutical and biomedical analysis"},{"issue":"5\u20136","key":"ref14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10928-005-0078-3","article-title":"Sample size computations for PK\/PD population models","volume":"32","author":"D Kang","year":"2005","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"ref15","first-page":"121","article-title":"Albendazole: a review of anthelmintic efficacy and safety in humans","author":"J. Horton","year":"2000","journal-title":"Parasitology"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.pt.2005.08.014","article-title":"Ivermectin 20 years on: maturation of a wonder drug","volume":"21","author":"TG Geary","year":"2005","journal-title":"Trends in parasitology"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/00912700222011247","article-title":"Pharmacokinetics of diethylcarbamazine after single oral dose at two different times of day in human subjects","volume":"42","author":"S Bolla","year":"2002","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1179\/000349803235001697","article-title":"The co-administration of ivermectin and albendazole\u2014safety, pharmacokinetics and efficacy against Onchocerca volvulus","volume":"97","author":"K Awadzi","year":"2003","journal-title":"Annals of tropical medicine and parasitology"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/infdis\/jix578","article-title":"Changes in Cytokine, Filarial Antigen, and DNA Levels Associated With Adverse Events Following Treatment of Lymphatic Filariasis","volume":"217","author":"BJ Andersen","year":"2018","journal-title":"The Journal of infectious diseases"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"e0006454","DOI":"10.1371\/journal.pntd.0006454","article-title":"Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature","volume":"12","author":"PJ Budge","year":"2018","journal-title":"PLoS neglected tropical diseases"},{"issue":"21","key":"ref21","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1001\/jama.1988.03720210040026","article-title":"Ivermectin for the treatment of Wuchereria bancrofti filariasis. Efficacy and adverse reactions","volume":"259","author":"V Kumaraswami","year":"1988","journal-title":"JAMA"},{"key":"ref22","article-title":"A Trial of a Triple Drug Treatment for Lymphatic Filariasis","author":"CL King","year":"2018","journal-title":"The New England journal of medicine"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/clinids\/13.5.1018","article-title":"Experimental infection of humans with filariae","volume":"13","author":"TB Nutman","year":"1991","journal-title":"Reviews of infectious diseases"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0035-9203(97)90405-3","article-title":"Assessment of the efficacy of diethylcarbamazine on adult Wuchereria bancrofti in vivo","volume":"91","author":"J Noroes","year":"1997","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0035-9203(96)90138-8","article-title":"Histological evidence for adulticidal effect of low doses of diethylcarbamazine in bancroftian filariasis","volume":"90","author":"J Figueredo-Silva","year":"1996","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4269\/ajtmh.2004.71.471","article-title":"Duplex Doppler sonographic assessment of the effects of diethylcarbamazine and albendazole therapy on adult filarial worms and adjacent host tissues in Bancroftian filariasis","volume":"71","author":"O Hussein","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"ref27","unstructured":"WHO. Guideline: Alternative mass drug administration regimens to eliminate lymphatic filariasis. Contract No.: WHO\/HTM\/NTD\/PCT\/2017.0. Geneva: 2017."}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0007325","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:00:00Z","timestamp":1559692800000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0007325","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T13:45:20Z","timestamp":1589031920000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0007325"}},"subtitle":[],"editor":[{"given":"Jennifer","family":"Keiser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,5,20]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0007325","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0007325","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,20]]}}}